UNSPSC 51283946: Sulfamonomethoxine

This classification denotes a sulfonamide anti-infective agent with the molecular formula C11H12N4O3S, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier U700P169W2, chemically known as sulfanilamide, n(sup 1)-(6-methoxy-4-pyrimidinyl)- but more generally known as sulfamonomethoxine, which bears U.S. National Institutes of Health Compound Identifier 5332. The European Medicines Agency schedules Sulfamonomethoxine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10716MIG.

UNSPSC 51283946 Sulfamonomethoxine is a Commodity code that captures pharmaceutical products, though the recent state and local opportunities tagged under it reflect broader pharmaceutical procurement activity rather than sulfamonomethoxine specifically. State and local health agencies, counties, and regional health systems procure pharmaceutical supplies — both branded and generic medications — through cooperative purchasing vehicles, piggyback contracts, and direct competitive bids. The solicitations under this code span antibiotics, opioid antagonists, and drug management systems acquired to support public health operations, emergency preparedness, and community health initiatives. Issuing bodies include state departments of public health, county health systems, and community health authorities.

Activity is sparse and geographically dispersed. Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC (Invitation for Bid, awarded August 28, 2026) for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets over a 12-month initial term with two one-year renewal options. Seminole County, Florida issued an IFB (June 30, 2026, due July 26, 2023) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building, Sanford. The code shows little activity directly tied to sulfamonomethoxine procurement; the tagging appears misaligned with the actual pharmaceutical products being solicited.